SCHEMBL6294653

SCHEMBL6294653

O=C(O)c1c(-c2ccccc2F)[nH]c2ccc(F)cc2c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 2/20 0.54
GLA P06280 1/20 0.54
GAA P10253 1/20 0.54
HTT P42858 1/20 0.54
TUBB4A P04350 2/20 0.46
TUBB P07437 2/20 0.46
TUBA3C P0DPH7 2/20 0.46
TUBA1B P68363 2/20 0.46
TUBA4A P68366 2/20 0.46
TUBB4B P68371 2/20 0.46
TUBB3 Q13509 2/20 0.46
TUBB2A Q13885 2/20 0.46
TUBB8 Q3ZCM7 2/20 0.46
TUBA3E Q6PEY2 2/20 0.46
TUBA1A Q71U36 2/20 0.46
TUBA1C Q9BQE3 2/20 0.46
TUBB6 Q9BUF5 2/20 0.46
TUBB2B Q9BVA1 2/20 0.46
TUBB1 Q9H4B7 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6295986 0.88 KDM4E (0.51) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6295994 0.88 MAP2 (0.45) KDM4EALDH1A1TUBB4ATUBBTUBA3C
SCHEMBL6295699 0.87 KDM4E (0.59) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6295691 0.85 TUBB4A (0.55) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6300675 0.84 ABCG2 (0.54) KDM4EALDH1A1GAATUBB4ATUBB
SCHEMBL6295738 0.83 ALOX5 (0.60) KDM4EALDH1A1GLAGAAHTT
SCHEMBL25199917 0.82 KDM4E (0.42) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6294973 0.82 ALDH1A1 (0.52) KDM4EALDH1A1GLAGAAHTT
SCHEMBL25215123 0.79 FEN1 (0.43) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6294977 0.78 ALDH1A1 (0.48) KDM4EALDH1A1GLAGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897316-B2 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-05-24 US disclosed
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHUK KDM4E 1042/4885ALDH1A1 465/4885GLA 1754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.